MainlyAI

MainlyAI is a Sweden-based research and technology company focused on developing and providing a platform as a service (PaaS) that enables secure, privacy-preserving data sharing and AI/ML collaboration for businesses and research organizations. Their platform simplifies the adoption of AI technologies, supports decision-making, trend analysis, automation, and is applied to sustainability, biotech, and healthcare-related projects in partnership with companies such as Diamyd Medical and academic institutions like KTH Royal Institute of Technology[1][2][5]. MainlyAI is not directly involved in drug development or clinical trials, but its technology is used to support biotech, pharma, and precision medicine initiatives, particularly in diabetes screening and sustainable pharmaceutical production[1][2][5].